Gossamer Bio Inc at UBS Global Healthcare Conference Transcript
Okay. Good afternoon, everyone. Thank you so much for joining us on Day 3 of the UBS Global Healthcare Conference. I'm Eli Merle. I'm one of the Biotech Analysts here at UBS. Very happy to have Gossamer Bio here with us for a fireside chat. Joining us from Gossamer Bio is Bryan Giraudo, Chief Financial Officer; and Richard Aranda, Chief Medical Officer.
Thank you guys so much for joining. Maybe before we jump into the specific programs, if you could frame for us some of the history of Gossamer as well as high level, how you're thinking about the strategy, asset prioritization and the key milestones from here?
Absolutely. And Eli, thank you for having us to the UBS team. Great to be part of first in-person conference back again for health care. Gossamer was founded in January 2018 with a mission to really find differentiated programs for a variety of immunologic conditions. We started with a fairly broad portfolio of a number of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
